BRIEF-CG Oncology Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort A

Reuters12-05 21:38

BRIEF-<a href="https://laohu8.com/S/CGON">CG Oncology</a> Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort A

Dec 5 (Reuters) - CG Oncology Inc CGON.O:

CG ONCOLOGY INC - ANNOUNCED TOPLINE DATA FROM BOND-003 COHORT P AND FIRST RESULTS FROM CORE-008 COHORT A
CG ONCOLOGY INC - BOND-003 COHORT P TRIAL SHOWS ENCOURAGING HG-EFS AND WELL-TOLERATED SAFETY PROFILE
CG ONCOLOGY INC - CORE-008 COHORT A SHOWS PROMISING EFFICACY, TOLERABILITY AND SAFETY

Source text: ID:nGNX3h4bwY

Further company coverage: CGON.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2589389013?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-05 21:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589389013","market":"us","top_or_hot":-1,"title":"BRIEF-CG Oncology Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort A","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/CGON\">CG Oncology</a> Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort A</title></head><body><p><span>Dec 5 (Reuters)</span><span> - </span>CG Oncology Inc <span>CGON.O</span>:</p><ul><li><p>CG ONCOLOGY INC - ANNOUNCED TOPLINE DATA FROM BOND-003 <a href=\"https://laohu8.com/S/CHRT.UK\">COHORT</a> P AND FIRST RESULTS FROM CORE-008 COHORT A</p></li><li><p>CG ONCOLOGY INC - BOND-003 COHORT P TRIAL SHOWS ENCOURAGING HG-EFS AND WELL-TOLERATED SAFETY PROFILE</p></li><li><p>CG ONCOLOGY INC - CORE-008 COHORT A SHOWS PROMISING EFFICACY, TOLERABILITY AND SAFETY</p></li></ul><p>Source text: <span>ID:nGNX3h4bwY</span></p><p>Further company coverage: <span>CGON.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-CG Oncology Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort A</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-CG Oncology Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort A\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-05 21:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/CGON\">CG Oncology</a> Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort A</title></head><body><p><span>Dec 5 (Reuters)</span><span> - </span>CG Oncology Inc <span>CGON.O</span>:</p><ul><li><p>CG ONCOLOGY INC - ANNOUNCED TOPLINE DATA FROM BOND-003 <a href=\"https://laohu8.com/S/CHRT.UK\">COHORT</a> P AND FIRST RESULTS FROM CORE-008 COHORT A</p></li><li><p>CG ONCOLOGY INC - BOND-003 COHORT P TRIAL SHOWS ENCOURAGING HG-EFS AND WELL-TOLERATED SAFETY PROFILE</p></li><li><p>CG ONCOLOGY INC - CORE-008 COHORT A SHOWS PROMISING EFFICACY, TOLERABILITY AND SAFETY</p></li></ul><p>Source text: <span>ID:nGNX3h4bwY</span></p><p>Further company coverage: <span>CGON.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGON","symbol_name":"CG Oncology Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XB0S6:1","article_id":"2589389013","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589389013","pubTimestamp":1764941922,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-CG Oncology Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort ADec 5 (Reuters) - CG Oncology Inc CGON.O:CG ONCOLOGY INC - ANNOUNCED TOPLINE DATA FROM BON","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CGON":"CG Oncology Inc.","BK4139":"生物科技"},"translate_title":"简介–CG Oncology Inc–公布Bond-003队列P的顶线数据和Core-008队列A的首次结果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGON":0.9},"content_text":"BRIEF-CG Oncology Inc - Announced Topline Data From Bond-003 Cohort P And First Results From Core-008 Cohort ADec 5 (Reuters) - CG Oncology Inc CGON.O:CG ONCOLOGY INC - ANNOUNCED TOPLINE DATA FROM BOND-003 COHORT P AND FIRST RESULTS FROM CORE-008 COHORT ACG ONCOLOGY INC - BOND-003 COHORT P TRIAL SHOWS ENCOURAGING HG-EFS AND WELL-TOLERATED SAFETY PROFILECG ONCOLOGY INC - CORE-008 COHORT A SHOWS PROMISING EFFICACY, TOLERABILITY AND SAFETYSource text: ID:nGNX3h4bwYFurther company coverage: CGON.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589389013","isCrawlerRequest":true}